Discrete role for cytosolic phospholipase A2α in platelets: Studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A2

Journal of Experimental Medicine

Volumn 196, Issue 3, 2002, Pages 349-357

  Wong, Dennis A ^a   Kita, Yoshihiro ^a   Uozumi, Naonori ^a   Shimizu, Takao ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bleeding; Knockout mice; Platelet aggregation; Thromboembolism; Thromboxane

Indexed keywords

ADENOSINE TRIPHOSPHATE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 ALPHA; THROMBOXANE A2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING TIME; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; GENETIC ENGINEERING; KNOCKOUT MOUSE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOEMBOLISM; VASOCONSTRICTION;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ANIMALS; BLEEDING TIME; BLOOD PLATELETS; COLLAGEN; CYTOSOL; HYDRAZINES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOLIPASES A; PLATELET AGGREGATION; THROMBOEMBOLISM; THROMBOXANE B2;

EID: 0037025894     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011443     Document Type: Article

References (62)

1. 2
2. Increased platelet sensitivity to ADP in mice lacking platelet-type 12-lipoxygenase
3. Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions
4. Lipid mediator networks in cell signaling: Update and impact of cytokines
5. Platelet-active drugs: The relationships among dose, effectiveness, and side effects
6. Congenital disorders of platelet function: Disorders of signal transduction and secretion
7. 2 binding activity
8. 2 receptor in a patient with a mild bleeding disorder: Deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation
9. 2
10. 2 in eicosanoid generation
11. 2 enzymes: Classification and characterization
12. 2s
13. 2
14. 2
15. 2
16. 2-β
17. Review article: Platelet-collagen interactions: Membrane receptors and intracellular signalling pathways
18. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: A platelet-specific collagen receptor from the immunoglobulin superfamily
19. 2 in allergic response and parturition
20. 2
21. Correction of symptoms of platelet storage pool deficiency in animal models for Chediak-Higashi syndrome and Hermansky-Pudlak syndrome
22. Platelet storage pool deficiency associated with inherited abnormalities of the inner ear in the mouse pigment mutants muted and mocha
23. 2 as defined by gene knockouts
24. 2 are resistant to MPTP neurotoxicity
25. 2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells
26. 2 in the production of lipid mediators and histamine release in mouse bone-marrow-derived mast cells
27. 2
28. 2 and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF
29. 2 gene
30. Min-induced tumorigenesis
31. 2
32. Min-induced intestinal neoplasia
33. 2 gene in inbred mouse strains
34. Native and mutant 5-lipoxygenase expression in a baculovirus/insect cell system
35. Bleeding time in laboratory animals. II - A comparison of different assay conditions in rats
36. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice
37. Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression
38. Mouse antithrombotic assay: A simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol
39. Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist
40. Aspects of the thromboxane receptor system
41. 2 receptor antagonists (13-APA, BM 1.3.177, ONO 3708 and SQ 29,548)
42. 4 pathway to inflammation control
43. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice
44. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice
45. 12-Lipoxygenases and 12(S)-HETE: Role in cancer metastasis
46. Eicosanoid regulation of angiogenesis: Role of endothelial arachidonate 12-lipoxygenase
47. Changes in glycoprotein expression after platelet activation: Differences between in vitro and in vivo studies
48. q-deficient mice
49. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice
50. Identification of the platelet ADP receptor targeted by antithrombotic drugs
51. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
52. Role of intracellular signaling events in ADP-induced platelet aggregation
53. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets
54. Collagen receptor signaling in platelets and megakaryocytes
55. Hematopoietic reconstitution of SLP-76 corrects hemostasis and platelet signaling through αIIbβ3 and collagen receptors
56. Evidence for the involvement of p59fyn and p53/56lyn in collagen receptor signalling in human platelets
57. The α2β1 integrin is a necessary, co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cγ2 in platelets
58. 2
59. 2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets
60. Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: Comparison with those of glycoprotein VI
61. Rhodocytin induces platelet aggregation by interacting with glycoprotein Ia/IIa (GPIa/IIa, Integrin α2β1). Involvement of GPIa/IIa-associated src and protein tyrosine phosphorylation
62. 2